Mid Day Update
By Brett Goldstein on May 04, 2007
9 Responses to “Mid Day Update”
Hey Blain. There is no chart for IBKR yet. It just started trading like 3 hours ago. I wasent able to sell my DNDN call for the price i wanted to so Im just gonna wait it out I guess. Good Luck and great site again.
I was able to get IBKR pre IPO… dropped my shares at 33 though because I expected a higher pop to begin with.
IBKR looks good, Sharebuilder released conditional offers @ around $27 per (75% sure). IPO came at top end of expectations, waiting to see a fall closer towards the low end before I jump in.
Check out my thoughts here:
http://www.wallstreetmatador.com/stock-charts/ibkrs-ipo-results/
WSM
JST is taking a beating. Earnings are always very volatile. I picked some more up though and just put a stop loss at 17.90. We`ll see how that works.
true, if i had known earnings was coming up i woudl have locked in some gains
oh well
Leave a Comment
Recent Blog Posts
- UPL (Ultra Petroleum) Stock Chart
- MT (ArcelorMittal) Stock Chart
- SPLS (Staples INC) Stock Chart
- KBX (Kimber Resources) Stock Chart
- WU (Western Union) Stock Chart
- GM (General Motors) Stock Chart
- CVV (CVD Equipment Corporation) Stock Chart
- GDOT (Green Dot) Stock Chart
- NOK (Nokia) Stock Chart
- Contact form 1
- Request A Stock Chart
- PETM (PETsMART) Stock Chart
- Request A Stock Chart
- SBUX ( Starbucks) Stock Chart
- TRMB (Trimble Navigation) Stock Chart
- ADES (ADA-ES) Stock Chart
- CLMT (Calumet Product Partners) Stock Chart
- PCYC (Pharmacyclics) Stock Chart
- RGR (Sturm Ruer) Stock Chart
- MAKO (Mako Surgical Corp) Stock Chart
- RCL (Royal Caribbean) Stock Chart
- GDOT (Green Dot Corp) Stock Chart
- NUE (Nucor Corp) Stock Chart
- RGR (Sturm Ruger) Stock Chart Update
- Cree (Cree) Stock Chart
- RGR (Strum Ruger) Stock Chart
- Mako (MAKO Surgical Corp) Stock Chart
- Mako (MAKO Surgical Corp) Stock Chart
- Cree (Cree) Stock Chart
- Cree (Cree) Stock Chart





is is IBKR pink sheet or something? not pulling up on my charting service, hmm…
DNDN is going to continue to be horribly volatile on both side of the equation, I believe it is the 15th FDA is supposed to make an announcement on their drug. Hopefully phase III trials are good.